Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × ensartinib × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 4 Carcinoma 2 The Diagnosis Was ALK Positive NSCLC 1 Solid Tumor 1 Neoplasms 1 Brain Neoplasms 1 ALK-positive Advanced NSCLC 1

Interventions

sotorasib 1 pembrolizumab 1 osimertinib 1 ensartinib 1 binimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02959619 2023-08-21

Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK

Betta Pharmaceuticals Co., Ltd.

Phase 1 Completed

Other solid neoplasmThoracic

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡